Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
Compassionate or expanded access involves making experimental drugs available to patients who are ineligible for the clinical trials of the drug. BCA urges the adoption of compassionate access programs in all clinical trials of new therapies, and the establishment of programs that make access available on a fair and impartial basis.
